Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Werewolf Therapeutics (HOWL) Return on Equity (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Return on Equity for 5 consecutive years, with 2.31% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 143.0% to 2.31% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.31% through Dec 2025, down 143.0% year-over-year, with the annual reading at 1.28% for FY2025, 51.0% down from the prior year.
  • Return on Equity for Q4 2025 was 2.31% at Werewolf Therapeutics, down from 2.05% in the prior quarter.
  • The five-year high for Return on Equity was 0.31% in Q4 2021, with the low at 2.31% in Q4 2025.
  • Average Return on Equity over 5 years is 0.75%, with a median of 0.46% recorded in 2022.
  • The sharpest move saw Return on Equity grew 15bps in 2023, then tumbled -143bps in 2025.
  • Over 5 years, Return on Equity stood at 0.31% in 2021, then crashed by -38bps to 0.43% in 2022, then rose by 24bps to 0.32% in 2023, then crashed by -172bps to 0.88% in 2024, then plummeted by -163bps to 2.31% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 2.31%, 2.05%, and 1.48% for Q4 2025, Q3 2025, and Q2 2025 respectively.